Viatris Inc.

NASDAQ:VTRS

12.93 (USD) • At close November 12, 2024
Bedrijfsnaam Viatris Inc.
Symbool VTRS
Munteenheid USD
Prijs 12.93
Beurswaarde 15,433,118,700
Dividendpercentage 4.31%
52-weken bereik 9.08 - 13.62
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Scott Andrew Smith
Website https://www.viatris.com

An error occurred while fetching data.

Over Viatris Inc.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious

Vergelijkbare Aandelen

BioMarin Pharmaceutical Inc. logo

BioMarin Pharmaceutical Inc.

BMRN

66.13 USD

Bio-Techne Corporation logo

Bio-Techne Corporation

TECH

74.41 USD

Insulet Corporation logo

Insulet Corporation

PODD

275.1 USD

Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc.

ALNY

268.95 USD

Henry Schein, Inc. logo

Henry Schein, Inc.

HSIC

67.46 USD

Incyte Corporation logo

Incyte Corporation

INCY

80.58 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)